Literature DB >> 17666586

Autocrine growth hormone: effects on growth hormone receptor trafficking and signaling.

Monique J van den Eijnden1, Ger J Strous.   

Abstract

GH and GH receptor are expressed in many extrapituitary tissues, permitting autocrine/paracrine activity. Autocrine GH has regulatory functions in embryonic development and cellular differentiation and proliferation and is reported to be involved in the development and metastasis of tumor cells. To understand the principles of transport and signaling of autocrine GH and GH receptor, we used a model system to express both proteins in the same cell. Our experiments show that GH binds the GH receptor immediately after synthesis in the endoplasmic reticulum and facilitates maturation of GH receptor. The hormone-receptor complexes arrive at the cell surface where exogenously added GH is unable to bind these receptors. Autocrine GH activates the GH receptors, but signal transduction occurs only after exiting the endoplasmic reticulum. This model study explains why autocrine GH-producing cells may be insensitive for GH (antagonist) treatment and clarifies autocrine signaling events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666586     DOI: 10.1210/me.2007-0092

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  16 in total

Review 1.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Exogenous growth hormone promotes an epithelial-mesenchymal hybrid phenotype in cancerous HeLa cells but not in non-cancerous HEK293 cells.

Authors:  E M Olascoaga-Caso; E Tamariz-Domínguez; J C Rodríguez-Alba; E Juárez-Aguilar
Journal:  Mol Cell Biochem       Date:  2022-10-12       Impact factor: 3.842

3.  Multimeric growth hormone receptor complexes serve as signaling platforms.

Authors:  Magdalena Sedek; Lieke M van der Velden; Ger J Strous
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

Review 4.  Rational design of competitive prolactin/growth hormone receptor antagonists.

Authors:  Estelle Tallet; Vincent Rouet; Jean-Baptiste Jomain; Paul A Kelly; Sophie Bernichtein; Vincent Goffin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

Review 5.  Pharmacological chaperoning: a primer on mechanism and pharmacology.

Authors:  Nancy J Leidenheimer; Katelyn G Ryder
Journal:  Pharmacol Res       Date:  2014-02-14       Impact factor: 7.658

6.  Expression of a glycosylphosphatidylinositol-anchored ligand, growth hormone, blocks receptor signalling.

Authors:  François Guesdon; Yahia Kaabi; Aiden H Riley; Ian R Wilkinson; Colin Gray; David C James; Peter J Artymiuk; Jon R Sayers; Richard J Ross
Journal:  Biosci Rep       Date:  2012-12       Impact factor: 3.840

7.  The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.

Authors:  Mattias Vesterlund; Fahad Zadjali; Torbjörn Persson; Michael Lund Nielsen; Benedikt M Kessler; Gunnar Norstedt; Amilcar Flores-Morales
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

8.  Growth hormone promotes hair cell regeneration in the zebrafish (Danio rerio) inner ear following acoustic trauma.

Authors:  Huifang Sun; Chia-Hui Lin; Michael E Smith
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

9.  Neuronal gamma-aminobutyric acid (GABA) type A receptors undergo cognate ligand chaperoning in the endoplasmic reticulum by endogenous GABA.

Authors:  Ping Wang; Randa S Eshaq; Charles K Meshul; Cynthia Moore; Rebecca L Hood; Nancy J Leidenheimer
Journal:  Front Cell Neurosci       Date:  2015-05-18       Impact factor: 5.505

Review 10.  Growth hormone and reproduction: a review of endocrine and autocrine/paracrine interactions.

Authors:  Kerry L Hull; Steve Harvey
Journal:  Int J Endocrinol       Date:  2014-12-15       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.